Durability of platelet response after switching to avatrombopag from eltrombopag or romiplostim in immune thrombocytopenia

被引：3
作者：
Al-Samkari, Hanny [1 ,2 ,9 ]
Jiang, Debbie [3 ,4 ]
Gernsheimer, Terry [3 ,4 ]
Liebman, Howard [5 ]
Lee, Susie [5 ]
Bernheisel, Chelsea
Wojdyla, Matthew [6 ]
Vredenburg, Michael [6 ]
Cuker, Adam [7 ,8 ]
机构：
[1] Massachusetts Gen Hosp, Div Hematol, Boston, MA 02114 USA
[2] Harvard Med Sch, Boston, MA 02115 USA
[3] Univ Washington, Div Hematol, Seattle, WA USA
[4] Seattle Canc Care Alliance, Seattle, WA USA
[5] Univ Southern Calif, Keck Sch Med, Hematol, Los Angeles, CA USA
[6] Sobi Inc, Durham, NC USA
[7] Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA USA
[8] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA USA
[9] Massachusetts Gen Hosp, Div Hematol Oncol, Boston, MA 02114 USA
来源：
RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS | 2023年 / 7卷 / 03期
关键词：
avatrombopag; eltrombopag; immune thrombocytopenia; romiplostim; thrombopoietin receptor;
D O I：
10.1016/j.rpth.2023.100134
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：5
相关论文
共 50 条
  • [41] Could Antinuclear Antibody Positivity Be a Factor Affecting Treatment Response in Immune Thrombocytopenia Patients on Eltrombopag?
    Baysal, Mehmet
    Bas, Volkan
    Umit, Elif
    Kirkizlar, Hakki Onur
    Demir, Ahmet Muzaffer
    TURKISH JOURNAL OF HEMATOLOGY, 2022, 39 (01) : 38 - 42
  • [42] From chronic immune thrombocytopenia to severe aplastic anemia: recent insights into the evolution of eltrombopag
    Gill, Harinder
    Wong, Raymond S. M.
    Kwong, Yok-Lam
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2017, 8 (05) : 159 - 174
  • [43] Platelet response to romiplostim amongst patients with newly diagnosed, persistent, and chronic immune thrombocytopenia in routine clinical practice in Denmark, Sweden, and Norway
    Christiansen, Christian Fynbo
    Risbo, Nickolaj
    Ghanima, Waleed
    Linder, Marie
    Bahmanyar, Shahram
    Seesaghur, Anouchka
    Clouser, Mary
    Norgaard, Mette
    Sorensen, Henrik Toft
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 205 (04) : 1497 - 1507
  • [44] Avatrombopag Effectively Maintained Platelet Counts in a Patient with Immune Thrombocytopenia Who Was Intolerant to Tyrosine Kinase Inhibitor Therapy
    Maitland, Hillary S.
    AMERICAN JOURNAL OF CASE REPORTS, 2021, 22
  • [45] Spontaneous remission after a year of romiplostim in an adult patient with refractory primary immune thrombocytopenia
    Maria Perera
    Alexia Suarez
    Hugo Luzardo
    Jezabel Lopez
    Teresa Molero
    Annals of Hematology, 2012, 91 : 1497 - 1498
  • [46] Function of eltrombopag-induced platelets compared to platelets from control patients with immune thrombocytopenia
    Haselboeck, Johanna
    Kaider, Alexandra
    Pabinger, Ingrid
    Panzer, Simon
    THROMBOSIS AND HAEMOSTASIS, 2013, 109 (04) : 676 - 683
  • [47] Spontaneous remission after a year of romiplostim in an adult patient with refractory primary immune thrombocytopenia
    Perera, Maria
    Suarez, Alexia
    Luzardo, Hugo
    Lopez, Jezabel
    Molero, Teresa
    ANNALS OF HEMATOLOGY, 2012, 91 (09) : 1497 - 1498
  • [48] Development of Romiplostim for Treatment of Primary Immune Thrombocytopenia From a Pharmacokinetic and Pharmacodynamic Perspective
    Bing-Bing Yang
    Sameer Doshi
    Karen Arkam
    Janet Franklin
    Andrew T. Chow
    Clinical Pharmacokinetics, 2016, 55 : 1045 - 1058
  • [49] Restored platelet function after romiplostim treatment in a patient with immune thrombocytopenic purpura
    Gardiner, Elizabeth E.
    Thom, James Y.
    Al-Tamimi, Mohammad
    Hughes, Annette
    Berndt, Michael C.
    Andrews, Robert K.
    Baker, Ross I.
    BRITISH JOURNAL OF HAEMATOLOGY, 2010, 149 (04) : 625 - 628
  • [50] Population Pharmacokinetic and Pharmacodynamic Modeling and Effects on Platelet Counts of Different Dosages of Eltrombopag in Chinese Patients With Chronic Primary Immune Thrombocytopenia
    Wu, Kai
    Thapar, Mita
    Farrell, Colm
    Hayes, Siobhan
    Guo, Haiyi
    Hou, Ming
    Zhang, Jianping
    CLINICAL THERAPEUTICS, 2015, 37 (07) : 1382 - 1395
12345